Flexi Seal Control FMS
Serving Clients Nationwide From Our Texas Offices in Corpus Christi, San Antonio & Austin
Recent safety alerts by the U.S. Food and Drug Administration (FDA) indicate that a defective valve in the Flexi-Seal Control FMS device can result in expulsion of the device, rectal damage, necrosis, and death.
The regulatory authority further alleges that ConvaTec, the manufacturer of the Flexi-Seal CONTROL, failed to submit the device for regulatory review before marketing and distributing the defective product to health care facilities.
Flexi-Seal Control never submitted for regulatory review
According to the FDA, ConvaTec began marketing and distribution of the device without seeking regulatory review.
Although the company manufactured similar devices in the past, the recalled Flexi-Seal CONTROL Fecal Management System was significantly different from the previous versions and would have needed a 510(k) application submission to be considered for approval by the FDA.
Over a period of a year, the FDA has noted 13 adverse event reports in which the use of the Flexi-Seal CONTROL Fecal Management System has resulted in serious injury or death. Adverse events cited by the FDA include necrosis, ulceration, peeling skin, rectal damage, and death.